UNIQURE NV's ticker is QURE and the CUSIP is N90064101. A total of 161 filers reported holding UNIQURE NV in Q3 2019. The put-call ratio across all filers is 0.13 and the average weighting 0.4%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $1 | -50.0% | 158 | 0.0% | 0.00% | – |
Q2 2023 | $2 | -33.3% | 158 | 0.0% | 0.00% | – |
Q1 2023 | $3 | -25.0% | 158 | 0.0% | 0.00% | – |
Q4 2022 | $4 | -99.9% | 158 | 0.0% | 0.00% | – |
Q3 2022 | $3,000 | 0.0% | 158 | 0.0% | 0.00% | – |
Q2 2022 | $3,000 | 0.0% | 158 | 0.0% | 0.00% | – |
Q1 2022 | $3,000 | 0.0% | 158 | 0.0% | 0.00% | – |
Q4 2021 | $3,000 | -40.0% | 158 | 0.0% | 0.00% | – |
Q3 2021 | $5,000 | +66.7% | 158 | +88.1% | 0.00% | – |
Q2 2021 | $3,000 | 0.0% | 84 | 0.0% | 0.00% | – |
Q1 2021 | $3,000 | 0.0% | 84 | 0.0% | 0.00% | – |
Q4 2020 | $3,000 | -66.7% | 84 | -65.9% | 0.00% | – |
Q3 2020 | $9,000 | -71.9% | 246 | 0.0% | 0.00% | -100.0% |
Q2 2020 | $32,000 | +166.7% | 246 | 0.0% | 0.00% | – |
Q1 2020 | $12,000 | -29.4% | 246 | 0.0% | 0.00% | – |
Q4 2019 | $17,000 | +88.9% | 246 | +2.9% | 0.00% | – |
Q3 2019 | $9,000 | -52.6% | 239 | 0.0% | 0.00% | – |
Q2 2019 | $19,000 | +35.7% | 239 | 0.0% | 0.00% | – |
Q1 2019 | $14,000 | +133.3% | 239 | +40.6% | 0.00% | – |
Q3 2018 | $6,000 | 0.0% | 170 | 0.0% | 0.00% | – |
Q2 2018 | $6,000 | +50.0% | 170 | 0.0% | 0.00% | – |
Q1 2018 | $4,000 | – | 170 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Aquilo Capital Management, LLC | 841,471 | $15,786,000 | 5.69% |
Nantahala Capital Management | 2,901,929 | $54,440,000 | 3.52% |
INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 544,500 | $10,209,000 | 3.27% |
683 Capital Management, LLC | 1,373,600 | $25,768,000 | 1.99% |
PFM Health Sciences, LP | 2,393,311 | $44,899,000 | 1.62% |
Integral Health Asset Management, LLC | 433,000 | $8,123,000 | 1.58% |
Privium Fund Management B.V. | 238,998 | $4,283,000 | 1.56% |
Nantahala Capital Management | 1,000,000 | $18,760,000 | 1.21% |
Henry James International Management Inc. | 89,469 | $1,678,000 | 0.94% |
Altium Capital Management LP | 105,000 | $1,970,000 | 0.72% |